313 related articles for article (PubMed ID: 28081475)
1. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
[TBL] [Abstract][Full Text] [Related]
2. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
[TBL] [Abstract][Full Text] [Related]
3. Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome.
Kouga T; Shimbo H; Iai M; Yamashita S; Ishii A; Ihara Y; Hirose S; Yamakawa K; Osaka H
Brain Dev; 2015 Feb; 37(2):243-9. PubMed ID: 24819914
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
Inoue Y; Ohtsuka Y;
Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
[TBL] [Abstract][Full Text] [Related]
5. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2C19 Phenotypes on Clinical Efficacy of Stiripentol in Japanese Patients With Dravet Syndrome.
Yamamoto Y; Takahashi Y; Ikeda H; Imai K; Kagawa Y; Inoue Y
Ther Drug Monit; 2020 Apr; 42(2):302-308. PubMed ID: 31318844
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
Inoue Y; Ohtsuka Y;
Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
Jullien V; Chhun S; Rey E; Dulac O; Tod M; Chiron C; Pons G
Clin Pharmacokinet; 2015 May; 54(5):527-36. PubMed ID: 25503589
[TBL] [Abstract][Full Text] [Related]
10. Stiripentol open study in Japanese patients with Dravet syndrome.
Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
[TBL] [Abstract][Full Text] [Related]
11. Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Trojnar MK; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsy Res; 2010 Aug; 90(3):188-98. PubMed ID: 20493662
[TBL] [Abstract][Full Text] [Related]
12. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.
May TW; Boor R; Mayer T; Jürgens U; Rambeck B; Holert N; Korn-Merker E; Brandt C
Ther Drug Monit; 2012 Aug; 34(4):390-7. PubMed ID: 22743350
[TBL] [Abstract][Full Text] [Related]
14. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
[TBL] [Abstract][Full Text] [Related]
15. Stiripentol: efficacy and tolerability in children with epilepsy.
Perez J; Chiron C; Musial C; Rey E; Blehaut H; d'Athis P; Vincent J; Dulac O
Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.
Peigné S; Chhun S; Tod M; Rey E; Rodrigues C; Chiron C; Pons G; Jullien V
Clin Pharmacokinet; 2018 Jun; 57(6):739-748. PubMed ID: 28819726
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
Cao D; Ohtani H; Ogiwara I; Ohtani S; Takahashi Y; Yamakawa K; Inoue Y
Epilepsia; 2012 Jul; 53(7):1140-5. PubMed ID: 22578034
[TBL] [Abstract][Full Text] [Related]
18. Stiripentol: an example of antiepileptic drug development in childhood epilepsies.
Nabbout R; Chiron C
Eur J Paediatr Neurol; 2012 Sep; 16 Suppl 1():S13-7. PubMed ID: 22695038
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
[TBL] [Abstract][Full Text] [Related]
20. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
